Regeneron's antibody cocktail approved by FDA for Ebola

An antibody cocktail from Regeneron has been approved by the FDA as the first treatment for Ebola, offering hope that a similar approach could be used to combat COVID-19.

Regeneron’s Ebola drug heading for October verdict from FDA

Merck claims first-ever FDA approval for an Ebola vaccine

CHMP backs world’s first Ebola vaccine from MSD, NewLink

Merck & Co in pole position for Ebola vaccine approval as FD...

The FDA is to review Merck & Co’s Ebola vaccine, giving the US pharma a chance to grab a first approval within six months.

First effective Ebola treatment a step closer after breakthr...

Clinical trials of four experimental treatments for Ebola in the Congo have been halted early after two of the drugs showed compelling benefits in a breakthrough against the deadly virus.